Expression of the Transforming Growth Factor β Isoforms in Inflammatory Cells of Nasal Polyps

Objective: To determine the expression and the potential role of transforming growth factor β (TGF-β) in nasal polyposis. Design: Comparison of TGF-β expression between normal and inflammatory nasal mucosa and polyps; in inflammatory nasal polyps, characterization of the TGF-β isoforms expression and their potential location in macrophages and eosinophils. Setting: Patients and samples were selected at the Hopital Intercommunal, Creteil, France, and immunohistochemistry and immunoblots were performed at the Institut National de la Sante et de la Recherche Medicale U296 (Universite Paris XII, France). Subjects: Nasal polyps and nasal mucosa were sampled in 21 patients during ethmoidectomy, and muscosa was sampled in 6 healthy patients during rhinoplasty. Methods: Immunohistochemistry and Western blot analysis were performed using specific antibodies to TGF-β 1-3 , TGF-β 1 , TGF-β 2 , and TGF-β 3 isoforms. Double labeling was also performed using anti-TGF-β 1 antibody together with macrophages or eosinophil-specific antibodies. Results: The expression of TGF-β 1-3 was significantly higher in inflammatory nasal polyps than in inflammatory nasal mucosa and higher in inflammatory nasal mucosa than in nasal mucosa from healthy patients. Transforming growth factor β 1 was the main isoform detected in inflammatory nasal polyps, and it was present in numerous macrophages and in some eosinophils. Conclusions: Transforming growth factor β, mainly TGF-β 1 , is strongly expressed in inflammatory nasal mucosa, where it could be produced by macrophages and eosinophils. Transforming growth factor β could induce epithelium and connective tissue modifications and therefore be involved in the pathogenesis of nasal polyposis.